GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Capex-to-Revenue

Q2M Biotech AG (HAM:QBI) Capex-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Q2M Biotech AG's Capital Expenditure for the three months ended in . 20 was €0.00 Mil. Its Revenue for the three months ended in . 20 was €0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


Q2M Biotech AG Capex-to-Revenue Historical Data

The historical data trend for Q2M Biotech AG's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Capex-to-Revenue Chart

Q2M Biotech AG Annual Data
Trend
Capex-to-Revenue

Q2M Biotech AG Quarterly Data
Capex-to-Revenue

Competitive Comparison of Q2M Biotech AG's Capex-to-Revenue

For the Biotechnology subindustry, Q2M Biotech AG's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q2M Biotech AG's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q2M Biotech AG's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Q2M Biotech AG's Capex-to-Revenue falls into.



Q2M Biotech AG Capex-to-Revenue Calculation

Q2M Biotech AG's Capex-to-Revenue for the fiscal year that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

Q2M Biotech AG's Capex-to-Revenue for the quarter that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q2M Biotech AG  (HAM:QBI) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Q2M Biotech AG Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines